Robert H. Hopper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert H. Hopper has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- C. Anderson Engh
Anderson Orthopaedic Research Institute, Alexandria, Virginia
3 shared publications - Henry Ho
Anderson Orthopedic Research Institute, Alexandria, Virginia
3 shared publications William G. Hamilton
Anderson Orthopaedic Research Institute, Alexandria, VA; Inova Mount Vernon Hospital Joint Replacement Center, Alexandria, VA
3 shared publications- Alexander V. Strait
Anderson Orthopaedic Research Institute, Alexandria, VA, USA
2 shared publications Charles A. Engh
Anderson Orthopaedic Research Institute, Alexandria, Virginia; Inova Mount Vernon Hospital Joint Replacement Center, Alexandria, Virginia
2 shared publicationsEric J. Wilson
Anderson Orthopaedic Research Institute, Alexandria, Virginia, USA
2 shared publications
Latest Publications
- 1 July 2026
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 16 (3)
Fracture of an 18-mm Diameter Extensively Porous-Coated Femoral Stem 17.9 Years After Primary Total Hip Arthroplasty
Case: A 79-year-old man presented with progressive right thigh pain over 6 months and reliance on a cane. He had undergone primary total hip arthroplasty (THA) with a metal-on-metal bearing in 2007. In 2025, radiographs revealed a fracture of his 18-mm diameter extensively porous-coated, cobalt-chrome alloy femoral stem (Prodigy, DePuy Orthopaedics), prompting revision THA. To the best of our knowledge, this case represents the largest diameter fracture of this type of component reported to date. Conclusion: While fractures of smaller diameter stems are well-documented, clinicians should be aware that fatigue fractures can also occur in very large diameter components with a cylindrical distal geometry.
- 1 July 2026
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 16 (3)
Fracture of an 18-mm Diameter Extensively Porous-Coated Femoral Stem 17.9 Years After Primary Total Hip Arthroplasty
Case: A 79-year-old man presented with progressive right thigh pain over 6 months and reliance on a cane. He had undergone primary total hip arthroplasty (THA) with a metal-on-metal bearing in 2007. In 2025, radiographs revealed a fracture of his 18-mm diameter extensively porous-coated, cobalt-chrome alloy femoral stem (Prodigy, DePuy Orthopaedics), prompting revision THA. To the best of our knowledge, this case represents the largest diameter fracture of this type of component reported to date. Conclusion: While fractures of smaller diameter stems are well-documented, clinicians should be aware that fatigue fractures can also occur in very large diameter components with a cylindrical distal geometry.
- 12 June 2026
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41 (10) , S431-S436
What Factors Increase the Risk of Dislocation After Primary Total Hip Arthroplasty Using the Direct Anterior Approach?
- 12 June 2026
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 41 (10) , S431-S436
What Factors Increase the Risk of Dislocation After Primary Total Hip Arthroplasty Using the Direct Anterior Approach?
- 18 March 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 40 (8) , S328-S332
Vancouver B Fractures After Using Cementless Femoral Fixation: A Single Center Experience
- 18 March 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 40 (8) , S328-S332
Vancouver B Fractures After Using Cementless Femoral Fixation: A Single Center Experience
- 17 March 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 40 (7) , S43-S47
Collection of Patient-Reported Outcome Measures: Comparing Paper to Online Data Collection Among Knee Arthroplasty Patients
- 17 March 2025
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 40 (7) , S43-S47
Collection of Patient-Reported Outcome Measures: Comparing Paper to Online Data Collection Among Knee Arthroplasty Patients
- 1 September 2024
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 106-B (9) , 916-923
Outcomes of fixed versus mobile-bearing medial unicompartmental knee arthroplasty
Aims: The optimal bearing surface design for medial unicompartmental knee arthroplasty (UKA) remains controversial. The aim of this study was to compare outcomes of fixed-bearing (FB) and mobile-bearing (MB) UKAs from a single high-volume institution.Methods: Prospectively collected data were reviewed for all primary cemented medial UKAs performed by seven surgeons from January 2006 to December 2022. A total of 2,999 UKAs were identified, including 2,315 FB and 684 MB cases. The primary outcome measure was implant survival. Secondary outcomes included 90-day and cumulative complications, reoperations, component revisions, conversion arthroplasties, range of motion, and patient-reported outcome measures. Overall mean age at surgery was 65.7 years (32.9 to 94.3), 53.1% (1,593/2,999) of UKAs were implanted in female patients, and demographics between groups were similar (p > 0.05). The mean follow-up for all UKAs was 3.7 years (0.0 to 15.6).Results: Using revision for any reason as an endpoint, five-year survival for FB UKAs was 97.2% (95% CI 96.4 to 98.1) compared to 96.0% for MB (95% CI 94.1 to 97.9; p = 0.008). The FB group experienced fewer component revisions (14/2,315, 0.6% vs 12/684, 1.8%; p < 0.001) and conversion arthroplasties (38/2315, 1.6% vs 24/684, 3.5%; p < 0.001). A greater number of MB UKAs underwent revision due to osteoarthritis progression (FB = 21/2,315, 0.9% vs MB = 16/684, 2.3%; p = 0.003). In the MB group, 12 (1.8%) subjects experienced bearing dislocations which required revision surgery. There were 15 early periprosthetic tibia fractures (0.6%) in the FB group compared to 0 for MB (p = 0.035).Conclusion: In similar patient populations, FB UKAs demonstrated slightly higher survival than a commonly used MB design. Adverse event profiles differed by bearing type, with an increased risk of bearing dislocation and OA progression with MB designs, and early periprosthetic tibia fractures for FB designs.Cite this article: Bone Joint J 2024;106-B(9):916–923.
- 1 September 2024
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 106-B (9) , 916-923
Outcomes of fixed versus mobile-bearing medial unicompartmental knee arthroplasty
Aims: The optimal bearing surface design for medial unicompartmental knee arthroplasty (UKA) remains controversial. The aim of this study was to compare outcomes of fixed-bearing (FB) and mobile-bearing (MB) UKAs from a single high-volume institution.Methods: Prospectively collected data were reviewed for all primary cemented medial UKAs performed by seven surgeons from January 2006 to December 2022. A total of 2,999 UKAs were identified, including 2,315 FB and 684 MB cases. The primary outcome measure was implant survival. Secondary outcomes included 90-day and cumulative complications, reoperations, component revisions, conversion arthroplasties, range of motion, and patient-reported outcome measures. Overall mean age at surgery was 65.7 years (32.9 to 94.3), 53.1% (1,593/2,999) of UKAs were implanted in female patients, and demographics between groups were similar (p > 0.05). The mean follow-up for all UKAs was 3.7 years (0.0 to 15.6).Results: Using revision for any reason as an endpoint, five-year survival for FB UKAs was 97.2% (95% CI 96.4 to 98.1) compared to 96.0% for MB (95% CI 94.1 to 97.9; p = 0.008). The FB group experienced fewer component revisions (14/2,315, 0.6% vs 12/684, 1.8%; p < 0.001) and conversion arthroplasties (38/2315, 1.6% vs 24/684, 3.5%; p < 0.001). A greater number of MB UKAs underwent revision due to osteoarthritis progression (FB = 21/2,315, 0.9% vs MB = 16/684, 2.3%; p = 0.003). In the MB group, 12 (1.8%) subjects experienced bearing dislocations which required revision surgery. There were 15 early periprosthetic tibia fractures (0.6%) in the FB group compared to 0 for MB (p = 0.035).Conclusion: In similar patient populations, FB UKAs demonstrated slightly higher survival than a commonly used MB design. Adverse event profiles differed by bearing type, with an increased risk of bearing dislocation and OA progression with MB designs, and early periprosthetic tibia fractures for FB designs.Cite this article: Bone Joint J 2024;106-B(9):916–923.
- 11 March 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (9) , S24-S28
The CCJR® Charles A. Engh, Sr, MD. Excellence in Hip Research Award: The Evolution of Revision Hip Arthroplasty and Impact on the Trainee’s Experience
- 11 March 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (9) , S24-S28
The CCJR® Charles A. Engh, Sr, MD. Excellence in Hip Research Award: The Evolution of Revision Hip Arthroplasty and Impact on the Trainee’s Experience
- 1 March 2024
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 106-B (3 Supple A) , 44-50
Metal levels and glomerular filtration rate after unilateral Birmingham Hip Resurfacing
Metal levels and glomerular filtration rate after unilateral Birmingham Hip Resurfacing
- 1 March 2024
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 106-B (3 Supple A) , 44-50
Metal levels and glomerular filtration rate after unilateral Birmingham Hip Resurfacing
Metal levels and glomerular filtration rate after unilateral Birmingham Hip Resurfacing
- 27 March 2023
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 38 (6) , S308-S313.e2
Timing and Factors Associated With Revision for Infection After Primary Total Knee Arthroplasty Based on American Joint Replacement Registry Data
- 27 March 2023
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 38 (6) , S308-S313.e2
Timing and Factors Associated With Revision for Infection After Primary Total Knee Arthroplasty Based on American Joint Replacement Registry Data
- 11 December 2021
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 110 (5) , 1113-1119
Do total hip arthroplasty polyethylene liners without free radicals oxidize in vivo or ex vivo?
Crosslinking substantially reduces the wear of ultra‐high molecular weight polyethylene (UHMWPE) used in total hip arthroplasty (THA) but some reports have indicated that first generation liners manufactured without antioxidants may be vulnerable to in vivo oxidation. This study evaluated maximum oxidation using Fourier transform infrared spectroscopy per ASTM F2102‐06ε1 and linear head penetration using a coordinate measuring machine among 66 revision‐retrieved THA components with in vivo durations ranging from 0.02 to 24.6 years. These included 30 liners crosslinked with 5 Mrad of gamma radiation and then melted, 13 non‐crosslinked, never‐irradiated liners sterilized with gas plasma and 23 non‐crosslinked, never‐irradiated liners sterilized with ethylene oxide. All liners were vacuum‐sealed and stored at −20°C prior to analysis with the exception of three retrievals of each material type that were stored in air for 9.9 to 21.5 years. All 57 vacuum‐sealed and frozen retrievals demonstrated good oxidative stability with maximum oxidation indices (OIs) less than 1.0 and 75% (43/57) of these liners had maximum OIs less than 0.1. Linear penetration measurements were lower in the crosslinked liners compared to non‐crosslinked retrievals. Although instances of oxidation and embrittlement were found after ex vivo storage in air among liners that did not have free radicals at the time of implantation, in vivo oxidation does not appear to be a clinical concern through the first decade of service for crosslinked liners and at up to 25 years after surgery for non‐crosslinked liners.
- 11 December 2021
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 110 (5) , 1113-1119
Do total hip arthroplasty polyethylene liners without free radicals oxidize in vivo or ex vivo?
Crosslinking substantially reduces the wear of ultra‐high molecular weight polyethylene (UHMWPE) used in total hip arthroplasty (THA) but some reports have indicated that first generation liners manufactured without antioxidants may be vulnerable to in vivo oxidation. This study evaluated maximum oxidation using Fourier transform infrared spectroscopy per ASTM F2102‐06ε1 and linear head penetration using a coordinate measuring machine among 66 revision‐retrieved THA components with in vivo durations ranging from 0.02 to 24.6 years. These included 30 liners crosslinked with 5 Mrad of gamma radiation and then melted, 13 non‐crosslinked, never‐irradiated liners sterilized with gas plasma and 23 non‐crosslinked, never‐irradiated liners sterilized with ethylene oxide. All liners were vacuum‐sealed and stored at −20°C prior to analysis with the exception of three retrievals of each material type that were stored in air for 9.9 to 21.5 years. All 57 vacuum‐sealed and frozen retrievals demonstrated good oxidative stability with maximum oxidation indices (OIs) less than 1.0 and 75% (43/57) of these liners had maximum OIs less than 0.1. Linear penetration measurements were lower in the crosslinked liners compared to non‐crosslinked retrievals. Although instances of oxidation and embrittlement were found after ex vivo storage in air among liners that did not have free radicals at the time of implantation, in vivo oxidation does not appear to be a clinical concern through the first decade of service for crosslinked liners and at up to 25 years after surgery for non‐crosslinked liners.
- 17 May 2021
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 103 (14) , 1303-1311
Results of the First U.S. FDA-Approved Hip Resurfacing Device at 10-Year Follow-up
Background: The BIRMINGHAM HIP Resurfacing (BHR) system is a metal-on-metal hip implant system approved by the U.S. Food and Drug Administration in 2006. The approval required a multicenter, prospective, post-market-approval study. Our purpose is to report the current results at 10 years of follow-up. Methods: Between October 2006 and December 2009, 280 primary BHR procedures were performed at 5 sites. Outcome measures included Kaplan-Meier survivorship, reasons for revision, radiographic component stability and osteolysis, Harris hip scores, and metal levels including cobalt and chromium. The mean age at the time of the procedure was 51.3 ± 7.1 years, 74% (206) of 280 BHRs were implanted in male patients, the mean body mass index was 27.8 ± 4.4 kg/m2, and 95% (265) of 280 hips had a primary diagnosis of osteoarthritis. The mean follow-up among all 280 hips was 9.0 ± 2.5 years. Prior to 10-year follow-up, 20 hips were revised and 5 patients representing 5 hips had died. Among the remaining 255 hips, 218 (85%) met the minimum follow-up of 10 years. Results: The 10-year survival free from all-cause component revision was 92.9% (95% confidence interval [CI], 89.8% to 96.1%) for all hips and 96.0% (95% CI, 93.1% to 98.9%) among male patients <65 years old at the time of the procedure. Reasons for revision included femoral loosening (n = 5), femoral neck fracture (n = 3), pseudotumor (n = 3), osteolysis (n = 2), and acetabular loosening (n = 1), as well as 6 revisions for a combination of pain, noise, or metal levels. Among unrevised hips, the median Harris hip score improved from preoperatively (59) to 1 year postoperatively (99; p < 0.001) and remained stable through 10 years postoperatively (99; p = 0.08). Radiographically, 5% (10) of 218 unrevised hips had osteolysis with no component migration. Median metal levels had increased at 1 year postoperatively (cobalt: from 0.12 ppb preoperatively to 1.5 ppb at 1 year postoperatively, p < 0.001; chromium: from 0.6 ppb preoperatively to 1.7 ppb at 1 year postoperatively, p < 0.001), then remained stable through 5 years before slightly decreasing at 10 years postoperatively (cobalt: 1.3 ppb, p < 0.001; chromium: 1.4 ppb, p < 0.001). Conclusions: This prospective, multicenter, post-market-approval study demonstrated that the BHR implant system is safe and effective through 10 years of follow-up, particularly among young male patients. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
- 17 May 2021
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 103 (14) , 1303-1311
Results of the First U.S. FDA-Approved Hip Resurfacing Device at 10-Year Follow-up
Background: The BIRMINGHAM HIP Resurfacing (BHR) system is a metal-on-metal hip implant system approved by the U.S. Food and Drug Administration in 2006. The approval required a multicenter, prospective, post-market-approval study. Our purpose is to report the current results at 10 years of follow-up. Methods: Between October 2006 and December 2009, 280 primary BHR procedures were performed at 5 sites. Outcome measures included Kaplan-Meier survivorship, reasons for revision, radiographic component stability and osteolysis, Harris hip scores, and metal levels including cobalt and chromium. The mean age at the time of the procedure was 51.3 ± 7.1 years, 74% (206) of 280 BHRs were implanted in male patients, the mean body mass index was 27.8 ± 4.4 kg/m2, and 95% (265) of 280 hips had a primary diagnosis of osteoarthritis. The mean follow-up among all 280 hips was 9.0 ± 2.5 years. Prior to 10-year follow-up, 20 hips were revised and 5 patients representing 5 hips had died. Among the remaining 255 hips, 218 (85%) met the minimum follow-up of 10 years. Results: The 10-year survival free from all-cause component revision was 92.9% (95% confidence interval [CI], 89.8% to 96.1%) for all hips and 96.0% (95% CI, 93.1% to 98.9%) among male patients <65 years old at the time of the procedure. Reasons for revision included femoral loosening (n = 5), femoral neck fracture (n = 3), pseudotumor (n = 3), osteolysis (n = 2), and acetabular loosening (n = 1), as well as 6 revisions for a combination of pain, noise, or metal levels. Among unrevised hips, the median Harris hip score improved from preoperatively (59) to 1 year postoperatively (99; p < 0.001) and remained stable through 10 years postoperatively (99; p = 0.08). Radiographically, 5% (10) of 218 unrevised hips had osteolysis with no component migration. Median metal levels had increased at 1 year postoperatively (cobalt: from 0.12 ppb preoperatively to 1.5 ppb at 1 year postoperatively, p < 0.001; chromium: from 0.6 ppb preoperatively to 1.7 ppb at 1 year postoperatively, p < 0.001), then remained stable through 5 years before slightly decreasing at 10 years postoperatively (cobalt: 1.3 ppb, p < 0.001; chromium: 1.4 ppb, p < 0.001). Conclusions: This prospective, multicenter, post-market-approval study demonstrated that the BHR implant system is safe and effective through 10 years of follow-up, particularly among young male patients. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.